Fil LTD Sarepta Therapeutics, Inc. Transaction History

Fil LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $1.37 Million - $1.72 Million	-19,800 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $1.4 Million - $3.28 Million	19,386 Added 4682.61%	19,800 $1.48 Million
Q4 2020 Feb 08, 2021	SELL	$125.56 - $178.74 $4.4 Million - $6.26 Million	-35,033 Reduced 98.83%	414 $70,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $18.6 Million - $25.2 Million	-146,220 Reduced 80.49%	35,447 $4.98 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $3.99 Million - $7.37 Million	42,935 Added 30.95%	181,667 $29.1 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $22.4 Million - $35.8 Million	-272,240 Reduced 66.24%	138,732 $13.6 Million
Q4 2019 Feb 07, 2020	SELL	$76.53 - $135.58 $141 Million - $250 Million	-1,843,960 Reduced 81.77%	410,972 $53 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $35.1 Million - $75.7 Million	482,428 Added 27.22%	2,254,932 $170 Million
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $60.9 Million - $82.4 Million	542,533 Added 44.11%	1,772,504 $269 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $36.1 Million - $51.4 Million	-338,895 Reduced 21.6%	1,229,971 $147 Million
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $21.9 Million - $33.4 Million	-224,835 Reduced 12.53%	1,568,866 $171 Million
Q3 2018 Nov 09, 2018	BUY	$115.31 - $161.51 $83.4 Million - $117 Million	723,542 Added 67.61%	1,793,701 $290 Million
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $76.8 Million - $164 Million	1,070,159 New	1,070,159 $141 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.